FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069160 [Registered on: 19/06/2024] Trial Registered Prospectively
Last Modified On: 09/07/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Development of AI for early detection of diabetic foot complications. 
Scientific Title of Study   Design and Development of AI-based solution to predict the early stage of diabetic foot complications empowering diabetic foot care 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mariya Jiandani 
Designation  Associate Professor 
Affiliation  Physiotherapy School and Centre Seth G S Medical College and KEMH 
Address  Cardio thoracis vascular center Building, Room No 16, Ground Floor, Seth G S Medical College and KEM Hospital, Parel East, Mumbai, India

Mumbai
MAHARASHTRA
400012
India 
Phone  9820191106  
Fax    
Email  mpjiandani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Mariya Jiandani 
Designation  Associate Professor 
Affiliation  Physiotherapy School and Centre Seth G S Medical College and KEMH 
Address  Cardio thoracis vascular center Building, Room No 16, Ground Floor, Seth G S Medical College and KEM Hospital, Parel East, Mumbai, India

Mumbai
MAHARASHTRA
400012
India 
Phone  9820191106  
Fax    
Email  mpjiandani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Taranga Joshi 
Designation  PG Student 
Affiliation  Physiotherapy School and Centre Seth G S Medical College and KEMH  
Address  Cardio thoracis vascular center Building, Room No 16, Ground Floor, Seth G S Medical College and KEM Hospital, Parel East, Mumbai, India

Mumbai
MAHARASHTRA
400012
India 
Phone  9987104222  
Fax    
Email  tarangajoshi106@gmail.com  
 
Source of Monetary or Material Support  
Physiotherapy School & Centre Seth G S Medical College & KEMH 
 
Primary Sponsor  
Name  Physiotherapy School & Centre Seth G S Medical College & KEMH  
Address  Room No 16, Ground Floor, CVTC Building, Physiotherapy School and Centre, Seth G S Medical College and KEM Hospital, Parel East, Mumbai 400012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mariya Jiandani  Physiotherapy School and Centre, Seth GS Medical College and KEM Hospital  Room No 16, Ground Floor, CVTC Building, Physiotherapy School and Centre, Seth G S Medical College and KEM Hospital, Parel East, Mumbai Mumbai MAHARASHTRA
Mumbai
MAHARASHTRA 
09820101196

mpjiandani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Seth GS Medical Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy human volunteers from age 30 to 70 without type 2 diabetes 
Patients  (1) ICD-10 Condition: E11||Type 2 diabetes mellitus, (2) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  People with type 2 diabetes mellitus
People with type 2 diabetes mellitus and diagnosed with diabetic foot complications
Normal Healthy individuals
Both gender (Male/Female)
30-70 years
 
 
ExclusionCriteria 
Details  People with venous foot ulcerations
People with bilateral Syme’s Amputation and above
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Development of machine learning algorithm for early detection of diabetic foot complication.  Baseline one time assessment  
 
Secondary Outcome  
Outcome  TimePoints 
App Usability questionnaire   Post 3 weeks of application delivery to the user 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Diabetes mellitus (DM) is a chronic, continually growing metabolic disease that can be brought on by an inability to produce insulin or by an intolerance to the hormone. The number of estimated sufferers in India is 77 million.  Diabetic foot complications (DFC) include neuropathies, calluses, poor circulation, and foot ulcers caused by ischemia, neuropathy, and microvascular and macrovascular damage. DFC is a common but serious complication of diabetes mellitus (DM). These issues contribute to morbidity and mortality by facilitating the development of infections, ulcers, and gangrene. Diabetic foot lesions not only result in pain and morbidity but also have major financial consequences. Early detection of DFC and foot care practices as a preventive measure have shown promising results in prevention of DFC. Hence the aim of the study is to develop and design AI based solution for early diagnosis of diabetic foot complications and to empower foot care practices.

 
Close